Skip to main content

Table 2 Synopsis of patients undergoing primary RPLND

From: Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

Patient (#) Primary tumour: % teratoma Primary tumour: Vascular inavasion Individual reason for RPLND Surgical result: nodes involved/nodes excised (n/n) Additional treatment Outcome
1 75% no Teratoma plus equivocal radiological finding 5/15 2xPEB NED 8 yr
2 20% no Patient’s choice 1/27 F/U NED 7 yr
3 40% no Lupus erythematodes, chronic glomerulonephritis 0/42 F/U NED 7 yr
4 60% yes Teratoma plus equivocal radiological finding 0/27 F/U NED 6 yr
5 20% yes chronic kidney disease due to congenital polycystic disease 0/22 F/U NED 5 yr
6 40% yes Equivocal radiological findings 0/30 F/U NED 4 yr
7 50% no Patient’s choice 0/26 F/U NED 4 yr
8 10% yes Equivocal radiological findings 1/33 F/U, NHL 1 year later AWSM 1 yr
9 95% no Teratoma plus equivocal radiological finding 0/24 F/U NED 3 yr
10 60% no Patient’s choice 0/39 F/U NED 3 yr
11 90% no Teratoma plus equivocal radiological finding 1/29 F/U NED 2 yr
12 0 yes Patient’s choice 1/10 2x PE NED 1 yr.
  1. PEB chemotherapy with cisplatin, etoposide, bleomycin; F/U follow-up, NHL Non Hodgkin lymphoma, NED no evidence of disease, AWSM alive with second malignancy, yr years